{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:25:34Z","timestamp":1789907134283,"version":"4.0.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["GOC8517N"],"award-info":[{"award-number":["GOC8517N"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s10875-018-0565-0","type":"journal-article","created":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T20:29:58Z","timestamp":1541104198000},"page":"836-843","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Warts and DADA2: a Mere Coincidence?"],"prefix":"10.1007","volume":"38","author":[{"given":"Katrijn","family":"Arts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna R. E.","family":"Bergerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda K.","family":"Ombrello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Similuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Oler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anahita","family":"Agharahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily M.","family":"Mace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Hershfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Wouters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lien","family":"De Somer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Anne","family":"Morren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca Perez-de","family":"Diego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leen","family":"Moens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra F.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1214-0302","authenticated-orcid":false,"given":"Isabelle","family":"Meyts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,1]]},"reference":[{"issue":"10","key":"565_CR1","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1056\/NEJMoa1307361","volume":"370","author":"Q Zhou","year":"2014","unstructured":"Zhou Q, Yang D, Ombrello AK, Zavialov AV, Toro C, Zavialov AV, et al. Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med. 2014;370(10):911\u201320.","journal-title":"N Engl J Med"},{"issue":"10","key":"565_CR2","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1056\/NEJMoa1307362","volume":"370","author":"P Navon Elkan","year":"2014","unstructured":"Navon Elkan P, Pierce SB, Segel R, Walsh T, Barash J, Padeh S, et al. Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Engl J Med. 2014;370(10):921\u201331.","journal-title":"N Engl J Med"},{"issue":"6","key":"565_CR3","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00431-014-2320-8","volume":"173","author":"N Garg","year":"2014","unstructured":"Garg N, Kasapcopur O, Foster J II, Barut K, Tekin A, Kizilkilic O, et al. Novel adenosine deaminase 2 mutations in a child with a fatal vasculopathy. Eur J Pediatr. 2014;173(6):827\u201330.","journal-title":"Eur J Pediatr"},{"issue":"5","key":"565_CR4","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1056\/NEJMc1405506","volume":"371","author":"J Van Montfrans","year":"2014","unstructured":"Van Montfrans J, Zavialov A, Zhou Q. Mutant ADA2 in vasculopathies. N Engl J Med. 2014;371(5):478.","journal-title":"N Engl J Med"},{"issue":"5","key":"565_CR5","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1056\/NEJMc1405506","volume":"371","author":"J Bras","year":"2014","unstructured":"Bras J, Guerreiro R, Santo GC. Mutant ADA2 in vasculopathies. N Engl J Med. 2014;371(5):478\u201380.","journal-title":"N Engl J Med"},{"issue":"5","key":"565_CR6","first-page":"480","volume":"371","author":"L Van Eyck","year":"2014","unstructured":"Van Eyck L, Liston A, Wouters C. Mutant ADA2 in vasculopathies. N Engl J Med. 2014;371(5):480.","journal-title":"N Engl J Med"},{"key":"565_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1546-0096-12-44","volume":"12","author":"A Belot","year":"2014","unstructured":"Belot A, Wassmer E, Twilt M, Lega JC, Zeef LA, Oojageer A, et al. Mutations in CECR1 associated with a neutrophil signature in peripheral blood. Pediatr Rheumatol Online J. 2014;12:44.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"565_CR8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jaci.2014.10.010","volume":"135","author":"L Van Eyck Jr","year":"2015","unstructured":"Van Eyck L Jr, Hershfield MS, Pombal D, Kelly SJ, Ganson NJ, Moens L, et al. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency. J Allergy Clin Immunol. 2015;135(1):283\u20137 e5.","journal-title":"J Allergy Clin Immunol"},{"issue":"20","key":"565_CR9","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1212\/WNL.0000000000001581","volume":"84","author":"WF Westendorp","year":"2015","unstructured":"Westendorp WF, Nederkoorn PJ, Aksentijevich I, Hak AE, Lichtenbelt KD, Braun KP. Unexplained early-onset lacunar stroke and inflammatory skin lesions: consider ADA2 deficiency. Neurology. 2015;84(20):2092\u20133.","journal-title":"Neurology"},{"issue":"8","key":"565_CR10","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.3899\/jrheum.150024","volume":"42","author":"ED Batu","year":"2015","unstructured":"Batu ED, Karadag O, Taskiran EZ, Kalyoncu U, Aksentijevich I, Alikasifoglu M, et al. A case series of adenosine deaminase 2-deficient patients emphasizing treatment and genotype-phenotype correlations. J Rheumatol. 2015;42(8):1532\u20134.","journal-title":"J Rheumatol"},{"issue":"11","key":"565_CR11","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1001\/jamadermatol.2015.1635","volume":"151","author":"TM Gonzalez Santiago","year":"2015","unstructured":"Gonzalez Santiago TM, Zavialov A, Saarela J, Seppanen M, Reed AM, Abraham RS, et al. Dermatologic features of ADA2 deficiency in cutaneous polyarteritis nodosa. JAMA Dermatol. 2015;151(11):1230\u20134.","journal-title":"JAMA Dermatol"},{"issue":"3","key":"565_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10875-016-0245-x","volume":"36","author":"J Schepp","year":"2016","unstructured":"Schepp J, Bulashevska A, Mannhardt-Laakmann W, Cao H, Yang F, Seidl M, et al. Deficiency of adenosine deaminase 2 causes antibody deficiency. J Clin Immunol. 2016;36(3):179\u201386.","journal-title":"J Clin Immunol"},{"issue":"8","key":"565_CR13","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/art.40147","volume":"69","author":"J Schepp","year":"2017","unstructured":"Schepp J, Proietti M, Frede N, Buchta M, Hubscher K, Rojas Restrepo J, et al. Screening of 181 patients with antibody deficiency for deficiency of adenosine deaminase 2 sheds new light on the disease in adulthood. Arthritis Rheumatol. 2017;69(8):1689\u2013700.","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"565_CR14","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1093\/rheumatology\/kev439","volume":"55","author":"JM Van Montfrans","year":"2016","unstructured":"Van Montfrans JM, Hartman EA, Braun KP, Hennekam EA, Hak EA, Nederkoorn PJ, et al. Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations. Rheumatology (Oxford). 2016;55(5):902\u201310.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"565_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2015-000236","volume":"2","author":"F Uettwiller","year":"2016","unstructured":"Uettwiller F, Sarrabay G, Rodero MP, Rice GI, Lagrue E, Marot Y, et al. ADA2 deficiency: case report of a new phenotype and novel mutation in two sisters. RMD Open. 2016;2(1):e000236.","journal-title":"RMD Open"},{"issue":"4","key":"565_CR16","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1007\/s00415-016-8070-y","volume":"263","author":"O Poswar Fde","year":"2016","unstructured":"Poswar Fde O, da Fonseca RM, de Albuquerque LC, Zhou Q, Jardim LB, Monte TL, et al. Adenosine deaminase 2 deficiency presenting as spastic paraplegia and systemic vasculitis. J Neurol. 2016;263(4):818\u201320.","journal-title":"J Neurol"},{"key":"565_CR17","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jpeds.2016.06.058","volume":"177","author":"T Ben-Ami","year":"2016","unstructured":"Ben-Ami T, Revel-Vilk S, Brooks R, Shaag A, Hershfield MS, Kelly SJ, et al. Extending the clinical phenotype of adenosine deaminase 2 deficiency. J Pediatr. 2016;177:316\u201320.","journal-title":"J Pediatr"},{"issue":"10","key":"565_CR18","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1182\/blood-2011-05-356352","volume":"118","author":"AP Hsu","year":"2011","unstructured":"Hsu AP, Sampaio EP, Khan J, Calvo KR, Lemieux JE, Patel SY, et al. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood. 2011;118(10):2653\u20135.","journal-title":"Blood"},{"issue":"9","key":"565_CR19","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1002\/art.39699","volume":"68","author":"S Nanthapisal","year":"2016","unstructured":"Nanthapisal S, Murphy C, Omoyinmi E, Hong Y, Standing A, Berg S, et al. Deficiency of adenosine deaminase type 2: a description of phenotype and genotype in fifteen cases. Arthritis Rheumatol. 2016;68(9):2314\u201322.","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"565_CR20","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1136\/annrheumdis-2016-210802","volume":"76","author":"R Caorsi","year":"2017","unstructured":"Caorsi R, Penco F, Grossi A, Insalaco A, Omenetti A, Alessio M, et al. ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study. Ann Rheum Dis. 2017;76(10):1648\u201356.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"565_CR21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12969-017-0193-x","volume":"15","author":"A Skrabl-Baumgartner","year":"2017","unstructured":"Skrabl-Baumgartner A, Plecko B, Schmidt WM, Konig N, Hershfield M, Gruber-Sedlmayr U, et al. Autoimmune phenotype with type I interferon signature in two brothers with ADA2 deficiency carrying a novel CECR1 mutation. Pediatr Rheumatol Online J. 2017;15(1):67.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"24","key":"565_CR22","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1182\/blood-2017-07-798660","volume":"130","author":"H Hashem","year":"2017","unstructured":"Hashem H, Kumar AR, Muller I, Babor F, Bredius R, Dalal J, et al. Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2. Blood. 2017;130(24):2682\u20138.","journal-title":"Blood"},{"issue":"5","key":"565_CR23","doi-asserted-by":"publisher","first-page":"e293","DOI":"10.1097\/MPH.0000000000000805","volume":"39","author":"H Hashem","year":"2017","unstructured":"Hashem H, Egler R, Dalal J. Refractory pure red cell aplasia manifesting as deficiency of adenosine deaminase 2. J Pediatr Hematol Oncol. 2017;39(5):e293\u2013e6.","journal-title":"J Pediatr Hematol Oncol"},{"key":"565_CR24","doi-asserted-by":"crossref","unstructured":"Alsutan A, Basher E, Alqanatish J et al (2018) Deficiency of ADA2 mimicking autoimmune lymphoprliferative syndrome in the absence of livedo reticularis and vasculitiis. Pediatric Blood Cancer 65:e26912","DOI":"10.1002\/pbc.26912"},{"key":"565_CR25","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.jaci.2018.01.012","volume":"141","author":"L Trotta","year":"2018","unstructured":"Trotta L, Martelius T, Siitonen T, Hautala T, Hamalainen S, Juntti H, et al. ADA2 deficiency: clonal lymphoproliferation in a subset of patients. J Allergy Clin Immunol. 2018;141:1534\u20131537.e8.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"565_CR26","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s10875-018-0480-4","volume":"38","author":"TF Michniacki","year":"2018","unstructured":"Michniacki TF, Hannibal M, Ross CW, Frame DG, DuVall AS, Khoriaty R, et al. Hematologic manifestations of deficiency of adenosine deaminase 2 (DADA2) and response to tumor necrosis factor inhibition in DADA2-associated bone marrow failure. J Clin Immunol. 2018;38(2):166\u201373.","journal-title":"J Clin Immunol"},{"key":"565_CR27","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s10875-018-0487-x","volume":"38","author":"FE Cipe","year":"2018","unstructured":"Cipe FE, Aydogmus C, Serwas NK, Keskindemirci G, Boztug K. Novel mutation in CECR1 leads to deficiency of ADA2 with associated neutropenia. J Clin Immunol. 2018;38:273\u20137.","journal-title":"J Clin Immunol"},{"key":"565_CR28","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/s41431-018-0130-6","volume":"26","author":"M Rama","year":"2018","unstructured":"Rama M, Duflos C, Melki I, Bessis D, Bonhomme A, Martin H, et al. A decision tree for the genetic diagnosis of deficiency of adenosine deaminase 2 (DADA2): a French reference centres experience. Eur J Hum Genet. 2018;26:960\u201371.","journal-title":"Eur J Hum Genet"},{"key":"565_CR29","doi-asserted-by":"publisher","unstructured":"Sundin M, Marits P, Nierkens S, Kolios AGA, Nilsson J. \u201cImmune\u201d thrombocytopenia as key feature of a novel ADA2 deficiency variant: implication on differential diagnostics of ITP in children. J Pediatr Hematol Oncol. 2018. https:\/\/doi.org\/10.1097\/MPH.0000000000001132","DOI":"10.1097\/MPH.0000000000001132"},{"key":"565_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.gene.2018.01.060","volume":"649","author":"R Gunthner","year":"2018","unstructured":"Gunthner R, Wagner M, Thurm T, Ponsel S, Hofele J, Lange-Sperandio B. Identification of co-occurrence in a patient with Dent's disease and ADA2-deficiency by exome sequencing. Gene. 2018;649:23\u20136.","journal-title":"Gene"},{"key":"565_CR31","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.jaci.2018.05.038","volume":"142","author":"PY Lee","year":"2018","unstructured":"Lee PY, Huang Y, Zhou Q, Schnappauf O, Hershfield MS, Li Y, et al. Disrupted N-linked glycosylation as a disease mechanism in deficiency of ADA2. J Allergy Clin Immunol. 2018;142:1363\u20131365.e8.","journal-title":"J Allergy Clin Immunol"},{"key":"565_CR32","unstructured":"Lamprecht P, Humrich JY, Diebold I, Riemekasten G. Diagnosis of deficiency of adenosine deaminase 2 with early onset polyarteritis nodosa in an adult patient with a novel compound heterozygous CECR1 mutation. Clin Exp Rheumatol 2018;36 Suppl 111(2):177."},{"key":"565_CR33","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.3389\/fimmu.2018.01361","volume":"9","author":"JM Springer","year":"2018","unstructured":"Springer JM, Gierer SA, Jiang H, Kleiner D, Deuitch N, Ombrello AK, et al. Deficiency of adenosine deaminase 2 in adult siblings: many years of a misdiagnosed disease with severe consequences. Front Immunol. 2018;9:1361.","journal-title":"Front Immunol"},{"key":"565_CR34","doi-asserted-by":"publisher","unstructured":"Sharma A, Naidu G, Chattopadhyay A, Acharya N, Jha S, Jain S. Novel CECR1 gene mutations causing deficiency of adenosine deaminase 2, mimicking antiphospholipid syndrome. Rheumatology (Oxford). 2018. https:\/\/doi.org\/10.1093\/rheumatology\/key258","DOI":"10.1093\/rheumatology\/key258"},{"issue":"5","key":"565_CR35","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10875-018-0525-8","volume":"38","author":"I Meyts","year":"2018","unstructured":"Meyts I, Aksentijevich I. Deficiency of adenosine deaminase 2 (DADA2): updates on the phenotype, genetics, pathogenesis, and treatment. J Clin Immunol. 2018;38(5):569\u201378.","journal-title":"J Clin Immunol"},{"issue":"1","key":"565_CR36","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12969-016-0111-7","volume":"14","author":"R Caorsi","year":"2016","unstructured":"Caorsi R, Penco F, Schena F, Gattorno M. Monogenic polyarteritis: the lesson of ADA2 deficiency. Pediatr Rheumatol Online J. 2016;14(1):51.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"8","key":"565_CR37","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/s10875-017-0449-8","volume":"37","author":"G Bucciol","year":"2017","unstructured":"Bucciol G, Delafontaine S, Segers H, Bossuyt X, Hershfield MS, Moens L, et al. Hematopoietic stem cell transplantation in ADA2 deficiency: early restoration of ADA2 enzyme activity and disease relapse upon drop of donor Chimerism. J Clin Immunol. 2017;37(8):746\u201350.","journal-title":"J Clin Immunol"},{"issue":"Pt 1","key":"565_CR38","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1042\/BJ20050683","volume":"391","author":"AV Zavialov","year":"2005","unstructured":"Zavialov AV, Engstrom A. Human ADA2 belongs to a new family of growth factors with adenosine deaminase activity. Biochem J. 2005;391(Pt 1):51\u20137.","journal-title":"Biochem J"},{"issue":"2","key":"565_CR39","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1189\/jlb.1109764","volume":"88","author":"AV Zavialov","year":"2010","unstructured":"Zavialov AV, Gracia E, Glaichenhaus N, Franco R, Zavialov AV, Lauvau G. Human adenosine deaminase 2 induces differentiation of monocytes into macrophages and stimulates proliferation of T helper cells and macrophages. J Leukoc Biol. 2010;88(2):279\u201390.","journal-title":"J Leukoc Biol"},{"issue":"5","key":"565_CR40","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/j.jaci.2012.07.049","volume":"130","author":"JW Leiding","year":"2012","unstructured":"Leiding JW, Holland SM. Warts and all: human papillomavirus in primary immunodeficiencies. J Allergy Clin Immunol. 2012;130(5):1030\u201348.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"565_CR41","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2174\/156800907780006869","volume":"7","author":"S Kanodia","year":"2007","unstructured":"Kanodia S, Fahey LM, Kast WM. Mechanisms used by human papillomaviruses to escape the host immune response. Curr Cancer Drug Targets. 2007;7(1):79\u201389.","journal-title":"Curr Cancer Drug Targets"},{"issue":"5","key":"565_CR42","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s10875-017-0407-5","volume":"37","author":"G Bucciol","year":"2017","unstructured":"Bucciol G, Willems L, Hauben E, Uyttebroeck A, Proesmans M, Meyts I. Thyroid carcinoma in a child with activated phosphoinositide 3-kinase delta syndrome: somatic effect of a germline mutation. J Clin Immunol. 2017;37(5):422\u20136.","journal-title":"J Clin Immunol"},{"issue":"2","key":"565_CR43","first-page":"178","volume":"4","author":"JG Niedzwicki","year":"1991","unstructured":"Niedzwicki JG, Kouttab NM, Mayer KH, Carpenter CC, Parks RE Jr, Abushanab E, et al. Plasma adenosine deaminase2: a marker for human immunodeficiency virus infection. J Acquir Immune Defic Syndr. 1991;4(2):178\u201382.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"565_CR44","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1128\/cdli.2.5.626-630.1995","volume":"2","author":"I Tsuboi","year":"1995","unstructured":"Tsuboi I, Sagawa K, Shichijo S, Yokoyama MM, Ou DW, Wiederhold MD. Adenosine deaminase isoenzyme levels in patients with human T-cell lymphotropic virus type 1 and human immunodeficiency virus type 1 infections. Clin Diagn Lab Immunol. 1995;2(5):626\u201330.","journal-title":"Clin Diagn Lab Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-018-0565-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-018-0565-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-018-0565-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T01:01:37Z","timestamp":1659056497000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-018-0565-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["565"],"URL":"https:\/\/doi.org\/10.1007\/s10875-018-0565-0","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"2 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}